Fig. 4From: Screening for immune-potentiating antigens from hepatocellular carcinoma patients after radiofrequency ablation by serum proteomic analysisFicolin-3, CLU and RBP4 levels in serum before and after radiofrequency (RFA) was compared in a validation set of 52 patients using ELISA. Results are expressed as the mean±SD. A P-value <0.05 was considered statistically significantBack to article page